Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Senin

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Archives of Gerontology and Geriatrics|January 1, 1996
Functional status and quality of life as main outcome measures of therapeutic efficacy in the elderlyU Senin, A Cherubini
Gerontology|January 1, 1986
Chronic cerebrovascular disorders: hemorheological and psychobehavioral aspectsL Parnetti, G Ciuffetti, U Senin
Minerva Medica|November 24, 1980
[Current knowledge of atherogenesis and prevention of atheromatous disease]A Ventura, E Mannarino, U Senin
Drugs|May 1, 1997
Cognitive enhancement therapy for Alzheimer's disease. The way forwardL Parnetti, U Senin, P Mecocci
Journal of the American Geriatrics Society|December 24, 1997
Increased oxidative damage in lymphocytes of Alzheimer's disease patientsP Mecocci, A Cherubini, U Senin
Bibliotheca Nutritio Et Dieta|January 1, 1983
Iron pathology in the elderlyA Ventura, U Senin, E Mannarino
Neuropsychobiology|January 1, 1995
Glycosaminoglycan polysulfate in primary degenerative dementia. Pilot study of biologic and clinical effectsL Parnetti, T A Ban, U Senin
Minerva Medica|March 31, 1970
[Clinical experience with cineangiocardioscintiphotography with Tc99 and a Gamma-Camera]R Palumbo, F Casamassima, U Senin, et al.
Clinical Therapeutics|March 1, 1993
Mental deterioration in old age: results of two multicenter, clinical trials with nimodipine. The Nimodipine Study GroupL Parnetti, U Senin, M Carosi, et al.
Biological Psychiatry|September 15, 1993
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementiaP Mecocci, R Ekman, L Parnetti, et al.
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Archives of Gerontology and Geriatrics|January 1, 1996
Functional status and quality of life as main outcome measures of therapeutic efficacy in the elderlyU Senin, A Cherubini
Gerontology|January 1, 1986
Chronic cerebrovascular disorders: hemorheological and psychobehavioral aspectsL Parnetti, G Ciuffetti, U Senin
Minerva Medica|November 24, 1980
[Current knowledge of atherogenesis and prevention of atheromatous disease]A Ventura, E Mannarino, U Senin
Drugs|May 1, 1997
Cognitive enhancement therapy for Alzheimer's disease. The way forwardL Parnetti, U Senin, P Mecocci
Journal of the American Geriatrics Society|December 24, 1997
Increased oxidative damage in lymphocytes of Alzheimer's disease patientsP Mecocci, A Cherubini, U Senin
Bibliotheca Nutritio Et Dieta|January 1, 1983
Iron pathology in the elderlyA Ventura, U Senin, E Mannarino
Neuropsychobiology|January 1, 1995
Glycosaminoglycan polysulfate in primary degenerative dementia. Pilot study of biologic and clinical effectsL Parnetti, T A Ban, U Senin
Minerva Medica|March 31, 1970
[Clinical experience with cineangiocardioscintiphotography with Tc99 and a Gamma-Camera]R Palumbo, F Casamassima, U Senin, et al.
Clinical Therapeutics|March 1, 1993
Mental deterioration in old age: results of two multicenter, clinical trials with nimodipine. The Nimodipine Study GroupL Parnetti, U Senin, M Carosi, et al.
Biological Psychiatry|September 15, 1993
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementiaP Mecocci, R Ekman, L Parnetti, et al.
Pageof 12